Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies

DH Kim, JH Cheon - Immune network, 2017 - synapse.koreamed.org
Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disorder with an
unknown etiology. IBD is composed of two different disease entities: Crohn's disease (CD) …

[PDF][PDF] Intestinal Behçet's disease: a true inflammatory bowel disease or merely an intestinal complication of systemic vasculitis?

DH Kim, JH Cheon - Yonsei medical journal, 2016 - synapse.koreamed.org
Behçet's disease (BD) is a multi-systemic inflammatory disorder of an unknown etiology and
shows a chronic recurrent clinical course. When the disease involves the alimentary tract, it …

[HTML][HTML] Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives

SJ Park, WH Kim, JH Cheon - World Journal of Gastroenterology …, 2014 - ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD) is a chronic, relapsing intestinal inflammatory disorder
with unidentified causes. Both environmental factors and genetic aspects are believed to be …

[HTML][HTML] Long-term Disease Course of Crohn's Disease: changes in Disease Location, phenotype, activities, and predictive factors

CW Cho, MW You, CH Oh, CK Lee, SK Moon - Gut and Liver, 2021 - pmc.ncbi.nlm.nih.gov
Crohn's disease (CD) is a chronic destructive inflammatory bowel disease that affects young
people and is associated with significant morbidity. The clinical spectrum and disease …

[PDF][PDF] Crohn's disease in Korea: past, present, and future

KM Lee, JM Lee - The Korean journal of internal medicine, 2014 - synapse.koreamed.org
The epidemiology, genetics, and clinical manifestations of Crohn's disease (CD) vary
considerably among geographic areas and ethnic groups. Thus, identifying the …

[HTML][HTML] Infliximab versus cyclosporine treatment for severe corticosteroid-refractory ulcerative colitis: a Korean, retrospective, single center study

EH Kim, DH Kim, SJ Park, SP Hong, TI Kim, WH Kim… - Gut and liver, 2015 - ncbi.nlm.nih.gov
Methods Between January 1995 and May 2012, the medical records of 43 patients with
corticosteroid-refractory UC who received either infliximab or cyclosporine as a rescue …

[HTML][HTML] Metronidazole-induced encephalopathy in a patient with Crohn's disease

J Kim, J Chun, JY Park, SW Hong, JY Lee… - Intestinal …, 2017 - synapse.koreamed.org
Metronidazole is a widely used antibiotic for the treatment of anaerobic bacterial infections.
Metronidazole-induced encephalopathy (MIEP) is a rare but potentially reversible disease …

Prevalencia de factores de riesgo cardiovasculares y el impacto en su calidad de vida entre los pacientes con enfermedad inflamatoria intestinal en el área de salud …

T García Guerrero - 2022 - dehesa.unex.es
La enfermedad inflamatoria intestinal (EIIC) es una enfermedad autoinflamatoria que afecta
tanto al intestino como a otros órganos. Hay evidencia de que otras enfermedades …

Evolução clínica da doença de Crohn no cenário de um hospital de referência brasileiro

KSC Barros - 2013 - lume.ufrgs.br
Introdução: A evolução clínica da Doença de Crohn (DC) é variável e influenciada por
fatores genéticos e ambientais. Há escassez de estudos no Brasil analisando a evolução e …

Identification of epithelial alarmins that promote activation of primary human lung fibroblasts

MI Suwara - 2013 - theses.ncl.ac.uk
Background Activation of the innate immune system plays a key role in exacerbations of
chronic lung disease, yet the role of fibroblasts in innate immune responses and the identity …